Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome
Recruiting
N/A
Interventional Study
Obesity & Overweight
Metabolic Syndrome
Gut Dysbiosis
Insulin Resistance
Dyslipidemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 50 (estimated)
- Sponsor
- JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Dietary fiber are components in foods that are not digested by human gastrointestinal enzymes (alpha amylase and alpha glucosidase) but are instead broken down and fermented by gut microbes. The byproducts generated during fermentation in the large intestine, primarily short-chain fatty acids (SCFA), bile acids, indoles, and their derivatives, circulate through the circulatory system to the liver,…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
* Adults aged 20-60 years.
* Willingness to provide informed consent.
* Willingness to consume Kodo millet porridge daily for 12 weeks.
* No planned changes in diet or physical activity during the study.
* Overweight or obese (BMI ≥ 25 kg/m²), placing them at risk for metabolic d…
Contacts